Romidepsin works by inhibiting HDAC enzymes, which play a crucial role in the regulation of gene expression. By blocking these enzymes, romidepsin leads to the accumulation of acetylated histones and other proteins, resulting in the reactivation of tumor suppressor genes and the induction of cell cycle arrest, differentiation, and apoptosis (programmed cell death) in cancer cells.
